Prevalence of and Risk Factors for Hepatic Steatosis and Nonalcoholic Fatty Liver Disease in People With Type 2 Diabetes: the Edinburgh Type 2 Diabetes Study

OBJECTIVE: Type 2 diabetes is an established risk factor for development of hepatic steatosis and nonalcoholic fatty liver disease (NAFLD). We aimed to determine the prevalence and clinical correlates of these conditions in a large cohort of people with type 2 diabetes. RESEARCH DESIGN AND METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Williamson, Rachel M., Price, Jackie F., Glancy, Stephen, Perry, Elisa, Nee, Lisa D., Hayes, Peter C., Frier, Brian M., Van Look, Liesbeth A.F., Johnston, Geoffrey I., Reynolds, Rebecca M., Strachan, Mark W.J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114489/
https://www.ncbi.nlm.nih.gov/pubmed/21478462
http://dx.doi.org/10.2337/dc10-2229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114489/
https://www.ncbi.nlm.nih.gov/pubmed/21478462
http://dx.doi.org/10.2337/dc10-2229

Ejemplares similares